TRPV4 and neoplasm: While LLC cells express TRPV4 (Fig. 2A; NEC were used as a positive control), treatment with TRPV4 activator GSK did not affect proliferation, confirming that GSK specifically inhibits proliferation of TEC, but not tumor epithelial cells (Fig. 2B).